Article Contents
Dallas, Texas–(Newsfile Corp. – June 18, 2024) – Stonegate Healthcare Partners, a leading healthcare consulting and market intelligence firm, announces the publication of a comprehensive thematic report entitled, “Cutting-Edge Innovations in Anti-Aging Dermatology,” which details innovative advancements in the treatment of age-related skin conditions, focusing on cutting-edge technologies and personalized, holistic approaches that have the potential to revolutionize the skin care industry.
Article Contents
To see the full announcement, including downloadable images, bios and more, click here.
Highlights:
- Emergence of new topical agents: Innovative products such as OneSkin’s OS-01, Sirona Biochem’s GlycoProteMim, and SK-II’s Pitera offer significant benefits that could take market share away from existing treatments.
- Personalized, holistic skin care: Advances in genomic science, skin diagnostics, and AI-driven tools enable customized treatment plans, ushering in a new era of skin care.
- Companies featured in the report are SkinMedica, SK-II, Sirona Biochem (TSXV: SBM), One Skin and CTEK Sisley.

To see the full announcement, click on the image above.
About Stonegate Healthcare Partners
Stonegate Healthcare Partners’ mission is to accelerate meaningful innovation in healthcare through strategy, market intelligence, business development and investor outreach. Our research approach is focused on comprehensive and comparative analysis of specific healthcare verticals. We seek to identify programs that are closely aligned with our strategic vision for the sector and focus on technologies with the greatest potential to bring about disruptive change. Stonegate Healthcare develops foundational thematic research by continually gathering market intelligence to better understand the current state of unmet needs and emerging disruptive technologies.
contact address:
Shiv Kapoor
email address
Source: Stonegate Healthcare
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/213432
#Distribution
Share this article on social networks
